Controlling and stopping the spread is possible, but only with help from across the full spectrum of global institutions.
In the shadow of a disease that moves quietly through communities before announcing itself in rash and fever, the World Health Organization and Africa's CDC have joined forces around a $135 million, six-month plan to contain mpox before it outpaces the world's capacity to respond. With more than 17,500 infections and 517 deaths recorded across a dozen African nations in 2024 alone, the outbreak has crossed the threshold from regional concern to global emergency — a designation the WHO does not invoke lightly. The plan is built not merely on medicine and money, but on the harder work of equity, solidarity, and the recognition that a virus unchecked anywhere is a threat everywhere.
- Mpox has already killed over 517 people and infected more than 17,500 across Africa in 2024, with the WHO warning that imported cases reaching other regions are increasingly likely.
- The WHO's August 14 global health emergency declaration — its highest alarm — signals that the window for containment is narrowing and that fragmented national responses will not be enough.
- A $135 million coordinated plan uniting the WHO and Africa's CDC under a single budget framework aims to synchronize surveillance, vaccination, and community engagement across affected nations.
- The United States is dispatching 10,000 vaccines to Africa this week, the EU is urging member states to donate before month's end, and UNICEF has appealed for $16 million — but funding gaps and distribution speed remain critical unknowns.
- A scientific conference on August 29–30 will align research priorities with outbreak response, while vaccination efforts focus first on healthcare workers and close contacts of confirmed cases to break transmission chains.
When the World Health Organization declared mpox a global health emergency on August 14, it was invoking a designation reserved for crises that demand the highest level of coordinated international mobilization. Days later, the WHO and Africa's CDC unveiled the response that declaration was meant to catalyze: a six-month, $135 million plan running through February 2025, built around five principles — equity, solidarity, community empowerment, human rights, and cross-sector coordination.
The outbreak is centered in the Democratic Republic of the Congo and neighboring countries, where it has killed more than 517 people and infected over 17,500 across more than a dozen African nations this year alone. The European CDC has noted that while the general European population faces low risk, travelers to affected regions face high exposure and imported cases are expected to rise — a reminder that this is no longer a contained regional emergency.
WHO Director-General Tedros Ghebreyesus was direct: stopping the spread is possible, but only through the full engagement of governments, institutions, and communities worldwide. The WHO and Africa's CDC have committed to a unified continental strategy — one plan, one budget — while allowing national and local authorities to adapt based on their own conditions. WHO incident management teams are being deployed to regional offices and headquarters, with staff significantly scaled up in affected countries.
International support is beginning to move. The United States is sending an initial 10,000 vaccines to Africa this week and has directed more than $2 billion in bilateral funding to Central and Eastern African nations for infectious disease response since last year. The European Commission has called on EU member states to coordinate vaccine donations before the end of August, drawing on lessons from COVID-19 about the cost of fragmented generosity. UNICEF has separately appealed for $16 million to scale its own preparedness efforts.
Mpox spreads through close contact with infected people or animals, with an incubation period of 3 to 17 days before symptoms — fever, rash, swollen lymph nodes, exhaustion — emerge. The 2022 global outbreak produced nearly 100,000 infections and around 200 deaths. This year's toll in Africa alone is already approaching those figures, and a scientific conference scheduled for August 29–30 will bring together leading research institutions to align mpox science with the urgent demands of outbreak control. The race is on.
On Monday, the World Health Organization and Africa's Centers for Disease Control announced a coordinated response to mpox that will run through February 2025, carrying a price tag of $135 million. The plan arrives after the WHO declared mpox a global health emergency on August 14, a designation reserved for threats that demand the organization's highest level of mobilization across its member states.
The outbreak is concentrated in the Democratic Republic of the Congo and neighboring countries, where it has already killed more than 517 people and infected over 17,500 others across more than a dozen African nations this year alone. But the virus is not contained to Africa. The European CDC has warned that while the general European population faces low risk, travelers to affected regions and those living there face high exposure, and imported cases are likely to increase. The emergency declaration signals that this is no longer a regional crisis—it is a global one requiring coordinated action.
WHO Director-General Tedros Ghebreyesus framed the challenge plainly: controlling and stopping the spread is possible, but only with help from across the full spectrum of global institutions, governments, and communities. The plan rests on five principles—equity, global solidarity, community empowerment, human rights, and cross-sector coordination. It will focus on comprehensive surveillance and prevention strategies, equitable access to diagnostics and vaccines, reducing animal-to-human transmission, and empowering communities to participate actively in outbreak control. At the strategic level, the emphasis is on leadership, evidence-based guidance, and ensuring that the most vulnerable populations in affected countries receive medical countermeasures first.
Africa's CDC and the WHO have committed to a "one-plan, one-budget approach" on the continent, developing what they call Africa's Continental Mpox Strategic Preparedness and Response Plan. National and local health authorities will adapt these strategies based on their own epidemiological conditions. The WHO is establishing incident management support teams at its regional offices and headquarters, significantly scaling up staff in affected nations to coordinate the response.
International support is already moving. The United States is sending a first batch of 10,000 mpox vaccines to Africa this week and has allocated more than $2 billion in bilateral funding to Central and Eastern African nations to combat infectious diseases since last year. The European Commission has urged EU member states to donate vaccines to Africa before the end of August, framing coordinated donations as more effective than uncoordinated ones—a lesson learned from the COVID-19 response. UNICEF has separately appealed for $16 million to scale up its own mpox response and preparedness across the region.
A virtual scientific conference scheduled for August 29-30 will bring together the Africa CDC, the Coalition for Epidemic Preparedness Innovations, and the National Institute of Allergy and Infectious Diseases to align mpox research with outbreak control goals. Vaccination efforts will prioritize the highest-risk groups: close contacts of confirmed cases and healthcare workers, with the goal of interrupting transmission chains before the virus spreads further.
Mpox spreads between people and certain animals, causing a distinctive rash on the hands, feet, chest, face, mouth, or genitals. The incubation period is 3 to 17 days, during which an infected person shows no symptoms. Once symptoms appear—fever, chills, swollen lymph nodes, exhaustion, muscle aches, headache, and respiratory symptoms—they typically emerge within 21 days of exposure. The 2022 global emergency declaration saw nearly 100,000 infections and roughly 200 deaths. This year's outbreak is already approaching those numbers in Africa alone, and the window to prevent global spread is narrowing.
Notable Quotes
Controlling and stopping the spread requires a comprehensive and coordinated plan of action between international agencies, national and local partners, civil society, researchers, manufacturers, and member states.— WHO Director-General Tedros Ghebreyesus
Coordinated vaccine donations will have more immediate impact if they are channeled through the Team Europe approach, as was successfully done during COVID-19.— European Commissioner for Health and Food Safety Stella Kyriakides
The Hearth Conversation Another angle on the story
Why did the WHO wait until August 14 to declare this a global emergency when cases were already climbing in the DRC?
The declaration itself is less about when the crisis started and more about when the organization decided the world needed to treat it as a coordinated problem. By mid-August, the scale was undeniable—over 17,000 cases, 517 deaths, spread across a dozen countries. That's the threshold that triggers the alarm.
The plan costs $135 million over six months. Is that a lot of money for a global health emergency?
In context, it's modest. The U.S. alone has already committed $2 billion to the region for infectious disease work. The real question isn't the number—it's whether the money actually reaches the places that need it, and whether it arrives before the virus does.
What does "one-plan, one-budget approach" actually mean for someone in the DRC?
It means the WHO and Africa's CDC are trying to avoid the chaos of multiple organizations running separate campaigns in the same country. Instead of five different vaccination strategies competing for the same healthcare workers, there's one coordinated effort. In theory, it's more efficient. In practice, it depends on whether local health authorities have the staff and supplies to execute it.
Why focus vaccination on healthcare workers and close contacts first instead of the general population?
You interrupt transmission chains at their weakest points. Healthcare workers are exposed repeatedly; close contacts are the next likely victims. If you vaccinate those groups, you slow the spread before it becomes a wildfire. It's triage, not fairness.
The European CDC says the risk to Europeans is low but warns travelers. Doesn't that seem contradictory?
Not really. It's saying the virus isn't circulating in Europe yet, so most Europeans are safe. But if you travel to an affected country, you're walking into an active outbreak. The warning is about imported cases—people who catch it abroad and bring it home. That's how outbreaks go global.
What happens if the vaccines don't arrive fast enough?
Then you get what happened in 2022—nearly 100,000 infections globally. This time, the infrastructure is better, the awareness is higher, and the response is faster. But speed matters. Every week of delay is thousands of potential exposures.